Exact Sciences Corp- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Exact Sciences Corp 公司

Exact Sciences Corporation 是一家全球先进的癌症诊断公司。该公司提供一系列用于早期癌症检测和治疗指导的产品。其产品和服务专注于筛查和精准肿瘤学测试。该公司的研发工作主要集中在三个主要领域：结直肠癌筛查、MCED 测试开发和 MRD 测试开发。该公司的产品和服务包括 Cologuard 测试、Oncotype DX 乳腺复发评分测试、Oncotype DX 乳腺 DCIS 评分测试、Oncotype DX 结肠复发评分测试和 OncoExTra 测试。该公司的旗舰筛查产品 Cologuard 测试是一种非侵入性、基于粪便的脱氧核糖核酸 (sDNA) 筛查测试，它利用多目标方法检测与结直肠癌和癌前病变相关的 DNA 和血红蛋白生物标志物。Oncotype DX 乳腺复发评分测试检查患者乳腺肿瘤组织中 21 个基因的活性。

Exact Sciences Corp简介



公司代码EXAS

公司名称Exact Sciences Corp

上市日期Jan 30, 2001

CEOMr. Kevin T. Conroy

员工数量6900

证券类型Ordinary Share

年结日Jan 30

公司地址5505 Endeavor Lane

城市MADISON

上市交易所NASDAQ Capital Market Consolidated

国家United States of America

邮编53719

电话16082845700

网址https://www.exactsciences.com/

公司代码EXAS

上市日期Jan 30, 2001

CEOMr. Kevin T. Conroy

Exact Sciences Corp公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Kevin T. Conroy

Chairman of the Board, President, Chief Executive Officer

1.14M

-20.54%

Ms. Katherine S. (Kay) Zanotti

Independent Director

60.76K

-16.49%

Mr. Daniel J. (Dan) Levangie

Independent Director

34.31K

+18.67%

Ms. Shacey Petrovic

Independent Director

28.90K

+22.97%

Mr. Brian Baranick

Executive Vice President, General Manager - Precision Oncology

23.04K

-11.04%

Ms. Leslie L. Trigg

Independent Director

17.17K

+80.75%

Ms. Kimberly J. (Kim) Popovits

Independent Director

16.38K

+156.47%

Mr. Aaron Bloomer

Chief Financial Officer, Executive Vice President

13.84K

--

Mr. Michael J. (Mike) Barber, M.D.

Independent Director

13.14K

+121.18%

Mr. James E. Doyle

Lead Independent Director

--

名称

名称/职务

职务

持股

持股变动

Mr. Kevin T. Conroy

Chairman of the Board, President, Chief Executive Officer

1.14M

-20.54%

Ms. Katherine S. (Kay) Zanotti

Independent Director

60.76K

-16.49%

Mr. Daniel J. (Dan) Levangie

Independent Director

34.31K

+18.67%

Ms. Shacey Petrovic

Independent Director

28.90K

+22.97%

Mr. Brian Baranick

Executive Vice President, General Manager - Precision Oncology

23.04K

-11.04%

Ms. Leslie L. Trigg

Independent Director

17.17K

+80.75%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Commercial

387.50M

47.78%

Medicare Parts B & C

274.49M

33.84%

Other

93.84M

11.57%

International

55.26M

6.81%

地区USD

名称

营收

占比

United States (Country)

755.83M

93.19%

Outside of united states

55.26M

6.81%

业务

地区

业务USD

名称

营收

占比

Commercial

387.50M

47.78%

Medicare Parts B & C

274.49M

33.84%

Other

93.84M

11.57%

International

55.26M

6.81%

股东统计

更新时间: 23 小时前

持股股东

股东类型

持股股东

占比

The Vanguard Group, Inc.

9.38%

Capital World Investors

8.52%

Fidelity Management & Research Company LLC

8.12%

BlackRock Institutional Trust Company, N.A.

3.78%

Wellington Management Company, LLP

2.81%

其他

67.40%

持股股东

占比

The Vanguard Group, Inc.

9.38%

Capital World Investors

8.52%

Fidelity Management & Research Company LLC

8.12%

BlackRock Institutional Trust Company, N.A.

3.78%

Wellington Management Company, LLP

2.81%

其他

67.40%

股东类型

持股股东

占比

Investment Advisor

52.84%

Investment Advisor/Hedge Fund

26.25%

Hedge Fund

6.43%

Pension Fund

2.25%

Research Firm

2.03%

Individual Investor

0.91%

Bank and Trust

0.56%

Sovereign Wealth Fund

0.48%

Private Equity

0.32%

其他

7.92%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

1362

183.28M

96.81%

-19.18M

2025Q2

1403

202.48M

106.98%

+2.53M

2025Q1

1424

199.78M

106.03%

-445.52K

2024Q4

1411

200.72M

108.09%

-225.66K

2024Q3

1375

190.82M

103.28%

-5.17M

2024Q2

1358

185.25M

100.40%

+6.59M

2024Q1

1347

168.41M

92.78%

-6.10M

2023Q4

1356

165.31M

91.41%

-11.01M

2023Q3

1337

167.70M

92.83%

-6.22M

2023Q2

1354

166.38M

92.24%

-10.65M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

17.87M

9.44%

+303.00K

+1.73%

Jun 30, 2025

Capital World Investors

18.20M

9.61%

+364.75K

+2.05%

Jun 30, 2025

Fidelity Management & Research Company LLC

23.28M

12.3%

-852.45K

-3.53%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

7.04M

3.72%

-640.89K

-8.35%

Jun 30, 2025

Wellington Management Company, LLP

12.00M

6.34%

-497.53K

-3.98%

Jun 30, 2025

State Street Investment Management (US)

5.38M

2.84%

-1.23M

-18.67%

Jun 30, 2025

MFS Investment Management

2.96M

1.57%

+1.46M

+97.24%

Jun 30, 2025

Geode Capital Management, L.L.C.

3.24M

1.71%

-29.40K

-0.90%

Jun 30, 2025

持股ETF



更新时间: 11月6日周四

机构名称

占比

First Trust Nasdaq Lux Digi Health Solutions ETF

3.78%

First Trust NYSE Arca Biotechnology Index Fund

3.27%

Invesco Biotechnology & Genome ETF

3.17%

Alger Mid Cap 40 ETF

2.49%

First Trust Indxx Medical Devices ETF

2.34%

SPDR S&P Biotech ETF

2.06%

iShares Health Innovation Active ETF

1.84%

Franklin Genomic Advancements ETF

1.81%

ROBO Global Healthcare Technology & Innovation ETF

1.74%

VanEck Biotech ETF

1.44%

First Trust Nasdaq Lux Digi Health Solutions ETF

占比3.78%

First Trust NYSE Arca Biotechnology Index Fund

占比3.27%

Invesco Biotechnology & Genome ETF

占比3.17%

Alger Mid Cap 40 ETF

占比2.49%

First Trust Indxx Medical Devices ETF

占比2.34%

SPDR S&P Biotech ETF

占比2.06%

iShares Health Innovation Active ETF

占比1.84%

Franklin Genomic Advancements ETF

占比1.81%

ROBO Global Healthcare Technology & Innovation ETF

占比1.74%

VanEck Biotech ETF

占比1.44%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据